# Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder

> **NCT01354314** · PHASE1,PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 45 (actual)

## Conditions studied

- HIV Associated Neurocognitive Disorder

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Paroxetine
- **DRUG:** Paroxetine and Fluconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01354314
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01354314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01354314, "Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01354314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*